BEIJING, Aug. 11 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, announced today that it is participating in the International FIME 2010 Show for medical manufacturers. The company will exhibit its Homecare Medical Products at Booth 125 at the Miami Beach Convention Center in Miami, Florida for three days, August 11 through August 13, 2010. Dehaier CEO Ping Chen will also be available to meet with members of the Chinese and international medical community who are gathered to attend the comprehensive medical tradeshow.
(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO )
(Logo: http://www.newscom.com/cgi-bin/prnh/20100422/CNTH001LOGO )
Mr. Chen said, "We are thrilled to be participating this year in the FIME Show, which is one of the largest medical manufacturing tradeshows for the international medical community. FIME draws medical distributors, hospital purchasing agents as well as clinicians and physicians from the U.S. and over 110 countries around the world including China. The event provides Dehaier significant exposure to the Chinese and international medical community in attendance, as well as providing networking for distribution and alliance opportunities with manufacturers of medical technology, medical products and supplies, medical equipment and services."
Additional information about FIME 2010 is available online at http://www.fimeshow.com/ .
About Dehaier Medical Systems Ltd.
Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded products from third party components. The company also distributes products designed and manufactured by other companies including medical devices and respiratory and oxygen homecare products from IMD (Italy), Welch Allyn (USA), Penlon (UK), HEYER (Germany), Timesco (UK), ResMed (Australia) and JMS (Japan). Dehaier's technology is based on two patents, five pending patents and proprietary technology. More information may be found at http://www.chinadhr.com .
Information for investors, including an investment profile about Dehaier is available at http://www.hawkassociates.com/profile/dhrm.cfm . An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors is available at http://www.hawkassociates.com .
Forward-looking Statements
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact:
Investor Contact:
Hawk Associates
Julie Marshall or Grace Huang
Tel: +1-305-451-1888
Email: dehaier@hawkassociates.com
